[go: up one dir, main page]

DE3685046D1 - Beschichtete transplantate und verfahren zu ihrer herstellung. - Google Patents

Beschichtete transplantate und verfahren zu ihrer herstellung.

Info

Publication number
DE3685046D1
DE3685046D1 DE8686301712T DE3685046T DE3685046D1 DE 3685046 D1 DE3685046 D1 DE 3685046D1 DE 8686301712 T DE8686301712 T DE 8686301712T DE 3685046 T DE3685046 T DE 3685046T DE 3685046 D1 DE3685046 D1 DE 3685046D1
Authority
DE
Germany
Prior art keywords
production
transplants
transplant
layer
bonding bridge
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686301712T
Other languages
English (en)
Inventor
Kent C Cochrum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California Berkeley
Original Assignee
University of California Berkeley
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley filed Critical University of California Berkeley
Application granted granted Critical
Publication of DE3685046D1 publication Critical patent/DE3685046D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/022Artificial gland structures using bioreactors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/34Macromolecular materials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/29Polyamino acid or polypeptide with an uninterrupted series of peptide repeating units

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Chemically Coating (AREA)
  • Prostheses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Fertilizers (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Catalysts (AREA)
  • Electroplating Methods And Accessories (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
DE8686301712T 1985-03-14 1986-03-11 Beschichtete transplantate und verfahren zu ihrer herstellung. Expired - Lifetime DE3685046D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71166485A 1985-03-14 1985-03-14

Publications (1)

Publication Number Publication Date
DE3685046D1 true DE3685046D1 (de) 1992-06-04

Family

ID=24859010

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686301712T Expired - Lifetime DE3685046D1 (de) 1985-03-14 1986-03-11 Beschichtete transplantate und verfahren zu ihrer herstellung.

Country Status (10)

Country Link
US (1) US4696286A (de)
EP (1) EP0195577B1 (de)
JP (1) JPH07100661B2 (de)
AT (1) ATE75409T1 (de)
CA (1) CA1267851A (de)
DE (1) DE3685046D1 (de)
DK (1) DK165221C (de)
FI (1) FI90628C (de)
IL (1) IL78110A (de)
NO (1) NO166836C (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935000A (en) * 1986-04-03 1990-06-19 East Carolina University Extracellular matrix induction method to produce pancreatic islet tissue
DE69018691T2 (de) * 1989-05-11 1995-08-17 Kanegafuchi Chemical Ind Medizinische Anordnung mit hochbiokompatibler Oberfläche und Verfahren zu deren Herstellung.
BR9007643A (pt) * 1989-09-15 1992-08-18 Chiron Ophthalmics Inc Metodo para se conseguir a epitelizacao de lentes sinteticas
IL103284A0 (en) * 1991-10-31 1993-02-21 Transtech Medical Inc Transplant protective coating
US5824331A (en) * 1992-02-24 1998-10-20 Encelle, Inc. Bioartificial devices and cellular matrices therefor
US5834005A (en) * 1992-02-24 1998-11-10 Encelle, Inc. Bioartificial devices and cellular matrices therefor
EP0587840B1 (de) * 1992-02-24 1999-12-15 Encelle, Inc. Künstliche endokrine vorrichtung
US6231881B1 (en) 1992-02-24 2001-05-15 Anton-Lewis Usala Medium and matrix for long-term proliferation of cells
US5578314A (en) * 1992-05-29 1996-11-26 The Regents Of The University Of California Multiple layer alginate coatings of biological tissue for transplantation
CA2135769A1 (en) * 1992-05-29 1993-12-09 Kent C. Cochrum Coated transplant and method for making same
US5429821A (en) * 1992-05-29 1995-07-04 The Regents Of The University Of California Non-fibrogenic high mannuronate alginate coated transplants, processes for their manufacture, and methods for their use
US5399665A (en) * 1992-11-05 1995-03-21 Massachusetts Institute Of Technology Biodegradable polymers for cell transplantation
AU6243294A (en) * 1993-02-18 1994-09-14 New England Deaconess Hospital Corporation Implantable artificial organ
AU695120B2 (en) * 1993-06-07 1998-08-06 Baylor College Of Medicine Use of an MHC class I suppressor drug for the treatment of autoimmune diseases and transplantation rejection
US5876742A (en) * 1994-01-24 1999-03-02 The Regents Of The University Of California Biological tissue transplant coated with stabilized multilayer alginate coating suitable for transplantation and method of preparation thereof
US6703017B1 (en) 1994-04-28 2004-03-09 Ixion Biotechnology, Inc. Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures
AU2517395A (en) * 1994-05-20 1995-12-18 Vec Tec, Inc. Methods rendering grafts nonthrombogenic and substantially nonimmunogenic
ATE423464T1 (de) * 1994-05-20 2009-03-15 Breonics Inc Verfahren zur überwachung der lebensfähigkeit transplantabler organe
US5882328A (en) * 1995-01-13 1999-03-16 Qlt Phototherapeutics, Inc. Method to prevent transplant rejection
US5916790A (en) * 1995-03-03 1999-06-29 Metabolex, Inc. Encapsulation compositions, and methods
EP0815212A1 (de) * 1995-03-03 1998-01-07 Metabolex, Inc. Neues enkapsulierungsverfahren mit einem gel-bildendem polymer
US6060640A (en) * 1995-05-19 2000-05-09 Baxter International Inc. Multiple-layer, formed-in-place immunoisolation membrane structures for implantation of cells in host tissue
EP0747046A3 (de) * 1995-05-19 1997-12-03 Baxter International Inc. Durchlässige Immunoisolationsmembranstrukturen für Zellimplantation in einem Wirtsgewebe
DE69637216D1 (de) * 1995-09-27 2007-10-04 Univ Emory Verwendung eines inhibitors eines kostimulatorischen vorgangs des immunsystems zur herstellung eines medikaments zum schutz transplantierter, nichtembryonaler lebender zellen vor zerstörung durch das immunsystem
US7041634B2 (en) 1995-09-27 2006-05-09 Emory University Method of inhibiting immune system destruction of transplanted viable cells
US5855613A (en) * 1995-10-13 1999-01-05 Islet Sheet Medical, Inc. Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change
ATE422857T1 (de) * 1995-10-26 2009-03-15 Paul P Latta Induktion von immunologischer toleranz
AU6496996A (en) * 1996-02-23 1997-09-10 Circle Biomedical, Inc. Novel artificial pancreas
US6364907B1 (en) 1998-10-09 2002-04-02 Qlt Inc. Method to prevent xenograft transplant rejection
AU1617800A (en) * 1998-11-12 2000-05-29 Polymer Biosciences, Inc. Hemostatic polymer useful for rapid blood coagulation and hemostasis
AU774185B2 (en) * 1999-06-05 2004-06-17 Board Of Trustees Of The Leland Stanford Junior University Method and composition for inhibiting cardiovascular cell proliferation
WO2001023528A1 (en) * 1999-09-27 2001-04-05 University Of Florida Research Foundation Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures
US20040208855A1 (en) * 1999-11-17 2004-10-21 Allison Beth Anne Use of PDT to inhibit intimal hyperplasia
AU4455301A (en) * 2000-03-21 2001-10-03 Sunao Kubota Coating materials for biological tissues, coated biological tissues and method of coating biological tissues
AU2001263495B2 (en) 2000-05-31 2005-06-02 Encelle, Inc. Method of treating chronic ulcers
AU2001273234A1 (en) * 2000-07-05 2002-01-14 Islet Technology, Inc. Method and system for consistent and effective encapsulation of biological material
KR100380569B1 (ko) * 2000-10-24 2003-04-26 주식회사 메디프렉스 고분자 결합을 이용한 췌장소도 막의 표면개질 방법
AU2002214443B2 (en) * 2000-11-03 2005-12-15 Vitrolife Ab Evaluation and preservation solution
WO2003057072A2 (en) * 2001-12-31 2003-07-17 Ares Laboratories, Llc Hemostatic compositions and methods for controlling bleeding
US20070248653A1 (en) * 2006-04-20 2007-10-25 Cochrum Kent C Hemostatic compositions and methods for controlling bleeding
AU2008214423A1 (en) * 2007-02-02 2008-08-14 Converge Biotech Inc. Therapeutic hybrid implantable devices
US20100021538A1 (en) * 2008-02-29 2010-01-28 Youngro Byun Pharmaceutical compositions containing heparin derivatives

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR6915369D0 (pt) * 1969-02-27 1973-03-13 Bayer Ag Emprego de inibidores biologicos de proteases para conservacao de orgaos tecidos e alimentos
US3629390A (en) * 1969-12-18 1971-12-21 Us Interior Avian specific bio-affecting preparation and treatment method
IL47062A (en) * 1975-04-10 1979-07-25 Yeda Res & Dev Process for diminishing antigenicity of tissues to be usedas transplants by treatment with glutaraldehyde
US4251387A (en) * 1979-04-17 1981-02-17 Damon Corporation Process for preparing semipermeable microcapsules
US4352883A (en) * 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4409331A (en) * 1979-03-28 1983-10-11 Damon Corporation Preparation of substances with encapsulated cells
US4391909A (en) * 1979-03-28 1983-07-05 Damon Corporation Microcapsules containing viable tissue cells
JPS6059010B2 (ja) * 1979-10-02 1985-12-23 工業技術院長 マイクロカプセル
US4353888A (en) * 1980-12-23 1982-10-12 Sefton Michael V Encapsulation of live animal cells
US4407957A (en) * 1981-03-13 1983-10-04 Damon Corporation Reversible microencapsulation of a core material
US4495288A (en) * 1981-03-13 1985-01-22 Damon Biotech, Inc. Method of culturing anchorage dependent cells
US4439521A (en) * 1981-10-21 1984-03-27 Ontario Cancer Institute Method for producing self-reproducing mammalian pancreatic islet-like structures
JPS6018179A (ja) * 1983-07-12 1985-01-30 三浦 喜温 人工肝臓用材料
CA1245984A (en) * 1983-09-01 1988-12-06 Damon Biotech, Inc. Polyionic microencapsulation
CA1215922A (en) * 1984-05-25 1986-12-30 Connaught Laboratories Limited Microencapsulation of living tissue and cells
GB8500121D0 (en) * 1985-01-03 1985-02-13 Connaught Lab Microencapsulation of living cells

Also Published As

Publication number Publication date
DK165221B (da) 1992-10-26
EP0195577A2 (de) 1986-09-24
FI861083L (fi) 1986-09-15
EP0195577A3 (en) 1988-08-03
IL78110A (en) 1991-04-15
DK119286A (da) 1986-09-15
JPS61222443A (ja) 1986-10-02
FI90628C (fi) 1994-03-10
ATE75409T1 (de) 1992-05-15
NO166836C (no) 1991-09-11
FI90628B (fi) 1993-11-30
IL78110A0 (en) 1986-07-31
NO860858L (no) 1986-09-15
NO166836B (no) 1991-06-03
JPH07100661B2 (ja) 1995-11-01
DK119286D0 (da) 1986-03-14
FI861083A0 (fi) 1986-03-14
CA1267851A (en) 1990-04-17
DK165221C (da) 1993-03-22
US4696286A (en) 1987-09-29
EP0195577B1 (de) 1992-04-29

Similar Documents

Publication Publication Date Title
DE3685046D1 (de) Beschichtete transplantate und verfahren zu ihrer herstellung.
DE68913215D1 (de) Verfahren zur Herstellung hydraulischer Dämpfungsspalten.
DE68900408D1 (de) Verfahren zur herstellung von aktivkohle tragenden wabenstrukturen.
ATA165086A (de) Verfahren zur herstellung von glaskoerperchen
DE58907317D1 (de) Verfahren zur Herstellung von Isocyanuratgruppen aufweisenden Polyisocyanaten.
DE3860618D1 (de) Filmtraeger und verfahren zu seiner herstellung.
DE3583421D1 (de) Zusammensetzung fuer kuenstlichen marmor und verfahren zu seiner herstellung.
DE3786046D1 (de) Verfahren zur herstellung von festkoerpern einrichtungen mit duennen dialektrischen schichten.
DE3579177D1 (de) Verfahren zur herstellung von werkstoffen mit gegen scherkraefte empfindlichen einlagen.
DE3683678D1 (de) Verfahren zur herstellung von nuetzlichen hochmolekulargewichtssubstanzen durch kultur von vermehrungsfaehigen tierzellen und dazu geeignetes kultursystem.
DE68916754D1 (de) Verfahren zur Herstellung von optisch aktiver 3-Hydroxybuttersäure.
DE3852939D1 (de) Verfahren zur Beschichtung künstlicher optischer Substrate.
DE68906431D1 (de) Verlaengerte elektrolumineszierende zelle sowie verfahren zur herstellung.
DE3485415D1 (de) Expressionsvektoren, solche vektoren enthaltende wirtszellen und verfahren zur herstellung gewuenschter produkte unter verwendung solcher zellen.
DE3872922D1 (de) Verfahren zur herstellung von lanthankuprat-einkristall.
DE3672500D1 (de) Farbige kontaktlinsen und verfahren zu ihrer herstellung.
EP0402796A3 (de) Verfahren zur Stabilisierung von auf Festphasen immobilisierten biologisch aktiven Substanzen
DE3583171D1 (de) Verfahren zur herstellung von kohlenstoffkoerpern.
DE69112977D1 (de) Verfahren zur Bestimmung von Reverse-Transkriptase unter Verwendung von immobilisierten Primern.
DE3482321D1 (de) Verfahren zur herstellung von bekannten herbiziden phenylcarbamaten.
DK0418725T3 (da) Fremgangsmåde til fremstilling af en beholder
DE3579782D1 (de) Verfahren zur herstellung von harnstoffgruppen enthaltenden polyisocyanaten.
DE58904105D1 (de) Verfahren zur herstellung von hexafluorpropen.
BR8502583A (pt) Aderente para a ligacao de superficies em municoes contendo cargas explosivas
DE3877437D1 (de) Verfahren zur herstellung von substraten fuer nachtraegliche stromlose metallisierung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee